Company / FCF Margin
Amneal Pharmaceuticals, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
8.9%
FY2025
5-year range
-2.8% / 9.3%
FY2021-FY2025
Trend
+2.8%
vs FY2024
Sector context
#47 of 134
Health Care
What the data says
At 8.9%, Amneal Pharmaceuticals, Inc.'s fcf margin ranks #47 of 134 in the Health Care sector. FCF Margin has fluctuated over the past 10 years, ranging from -2.8% in FY2021 to 13.5% in FY2019.
Based on SEC 10-K filings.
8.9% in FY2025 with a 5-year CAGR of -1.1%.
Declined from 9.3% to 8.9% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +8.1pp
- 5-Year Change
- -1.1pp
- 10-Year Change
- -
Sector benchmark
#47 of 134 in Health CareTop 35% of 134This company 8.9% Sector average -637.8%
▼
+101.4% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 2.8% year-over-year.
- Currently 646.7pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.9% | +2.8% |
| FY2024 | 8.7% | -6.1% |
| FY2023 | 9.3% | +1003.6% |
| FY2022 | 0.8% | +130.0% |
| FY2021 | -2.8% | -127.9% |
| FY2020 | 10.1% | -25.5% |
| FY2019 | 13.5% | +1875.0% |
| FY2018 | -0.8% | -105.6% |
| FY2017 | 13.5% | +1875.0% |
| FY2016 | -0.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026